HUDDINGE, Sweden, April 9, 2019 /PRNewswire/ --
Karo Pharma publishes its annual report for 2018.
Today, on 9 April 2019, Karo Pharma is publishing its annual report for 2018 on the company's website, www.karopharma.com.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Mats-Olof Wallin, CFO, +4676 002 60 10, firstname.lastname@example.org
ABOUT KARO PHARMA
Karo Pharma is a Specialty Pharma company, which develops and markets products for pharmacies as well as directly to the healthcare sector. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.
This information is information that Karo Pharma is obliged to make public pursuant to the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on 9 April, at 08:30 CEST. This press release is also available at www.karopharma.se and www.newsroom.cision.com.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
SOURCE Karo Pharma